BOSTON SCIENTIFIC CORP 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Lance Jean Fitterer
SVP & Chief Compliance Officer
Transactions
- Exercise/Conversion
Deferred Stock Units
2014-02-28−3,382→ 46,614 total→ Common Stock (3,382 underlying) - Sale
Common Stock
2014-02-28$13.20/sh−10,000$131,979→ 112,504 total - Exercise/Conversion
Common Stock
2014-02-28+4,190→ 121,667 total - Exercise/Conversion
Common Stock
2014-02-28+3,382→ 125,049 total - Tax Payment
Common Stock
2014-02-28$13.10/sh−2,545$33,340→ 122,504 total - Exercise/Conversion
Deferred Stock Units
2014-02-28−4,190→ 42,424 total→ Common Stock (4,190 underlying)
Holdings
- 7,661(indirect: By 401(k))
Common Stock
Footnotes (7)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.190 to $13.201, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- [F5]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
- [F6]Reflects multiple DSU awards with independent vesting schedules.
- [F7]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.